Polyarteritis nodosa: Difference between revisions

No edit summary
 
(5 intermediate revisions by 3 users not shown)
Line 3: Line 3:
*Skin, musculoskeletal, CNS, and GI tract (spares lung)
*Skin, musculoskeletal, CNS, and GI tract (spares lung)
*Predilection to arterial bifurcations and branch sites
*Predilection to arterial bifurcations and branch sites
*Microaneurysm, [[thromboemboli|thrombosis, emboli]], organ ischemia, and infarction
*Microaneurysm, [[thromboembolism|thrombosis, emboli]], organ ischemia, and infarction
*Etiology: Idiopathic, [[HBV]], [[hepatitis C|HCV]], hairy cell [[leukemia]]
*Etiology: Idiopathic, [[HBV]], [[hepatitis C|HCV]], hairy cell [[leukemia]]


==Evaluation==
{{Primary Vasculitis DDX}}
===Clinical Features===
 
==Clinical Features==
[[File:PMC3505767 ad-24-383-g005.png|thumb|Cutaneous polyarteritis nodosa. (A) The patient presented with livedo reticularis on the lower legs. (B) Vasculitis involves the muscular artery of the deep dermis.]]
*Cutaneous [[rash|lesion]] + adult onset [[hypertension]]
*Cutaneous [[rash|lesion]] + adult onset [[hypertension]]
*Men > women (2:1)
*Men > women (2:1)
Line 23: Line 25:
*[[Myocardial ischemia]] and [[heart failure]]
*[[Myocardial ischemia]] and [[heart failure]]
*[[Myalgia]] (elevated CK)
*[[Myalgia]] (elevated CK)
===Classification===
*American College of Rheumatology 10 criteria (at least 3, has 82% sensitivity and 87% specificity)
**Unexplained weight loss greater than 4kg
**Livedo reticularis
**[[Testicular Pain]] or tenderness
**Myalgia (excluding shoulder and hip girdle), weakness of muscles, tenderness of leg muscles, or polyneuropathy
**Mononeuropathy or polyneuropathy
**New-onset diastolic blood pressure > 90mmHg
**Elevated serum BUN (>40mg/dL or 14.3mmol/L) or creatinine (>1.5mg/dL or 132 mmol/L)
**Evidence of HBV infection (serology)
**Characteristic arteriographic abnormalities not resulting fro noninflammatory disease processes
**Biopsy of small- or medium-sized artery containing polymorphonuclear cells


==Differential Diagnosis==
==Differential Diagnosis==
*Embolism, thrombosis, atherosclerosis
*Embolism, thrombosis, atherosclerosis
*[[HIV]], [[Hepatitis]], IE, mycotic aneurysm
*[[HIV]], [[Hepatitis]], IE, [[mycotic aneurysm]]
*Fibromuscular dysplasia
*Fibromuscular dysplasia
*Microscopic polyangiitis, [[Granulomatosis with polyangiitis]] (Wegener's), [[Eosinophilic granulomatosis with polyangiitis]] (Churg-Strauss), IgA vasculitis, drug-induced vasculitis, [[connective tissue disease]], [[SLE]], cryoglobulinemic vasculitis
*Microscopic polyangiitis, [[Granulomatosis with polyangiitis]] (Wegener's), [[Eosinophilic granulomatosis with polyangiitis]] (Churg-Strauss), IgA vasculitis, drug-induced vasculitis, [[connective tissue disease]], [[SLE]], cryoglobulinemic vasculitis


==Evaluation==
==Evaluation==
===Workup===
*Definitive: Tissue biopsy
*Definitive: Tissue biopsy
*Labs:
*Labs:
Line 57: Line 46:
**CT/MRI
**CT/MRI
*Consider: [[CXR]], blood cultures, autoimmune serologic testing (ANCA, ANA, RF) to rule out other diseases
*Consider: [[CXR]], blood cultures, autoimmune serologic testing (ANCA, ANA, RF) to rule out other diseases
===Diagnosis===
====American College of Rheumatology Criteria====
''Need at least 3/10 (82% sensitivity and 87% specificity)''
*Unexplained weight loss greater than 4kg
*Livedo reticularis
*[[Testicular Pain]] or tenderness
*Myalgia (excluding shoulder and hip girdle), weakness of muscles, tenderness of leg muscles, or polyneuropathy
*Mononeuropathy or polyneuropathy
*New-onset diastolic blood pressure > 90mmHg
*Elevated serum BUN (>40mg/dL or 14.3mmol/L) or creatinine (>1.5mg/dL or 132 mmol/L)
*Evidence of HBV infection (serology)
*Characteristic arteriographic abnormalities not resulting fro noninflammatory disease processes
*Biopsy of small- or medium-sized artery containing polymorphonuclear cells


==Management==
==Management==

Latest revision as of 17:35, 2 August 2023

Background

  • Necrotizing vasculitis of small- and medium-sized blood vessels
  • Skin, musculoskeletal, CNS, and GI tract (spares lung)
  • Predilection to arterial bifurcations and branch sites
  • Microaneurysm, thrombosis, emboli, organ ischemia, and infarction
  • Etiology: Idiopathic, HBV, HCV, hairy cell leukemia

Vasculitis Syndrome Types

Clinical Features

Cutaneous polyarteritis nodosa. (A) The patient presented with livedo reticularis on the lower legs. (B) Vasculitis involves the muscular artery of the deep dermis.
  • Cutaneous lesion + adult onset hypertension
  • Men > women (2:1)
  • Peak age 40-60s
  • Systemic: Fatigue, weight loss, weakness, fever, arthralgia
  • Cutaneous lesions (1/3 patients)
    • Tender erythematous nodules
    • Palpable purpura (fingers, ankles, malleoli, pretibial)
    • Digital cyanosis
    • Splinter hemorrhages
    • Livedo reticularis
  • Renovascular arteritis → hypertension
  • Peripheral neuropathies (mononeuritis multiplex, polyneuropathy)
  • Mesenteric vasculitis (abdominal angina, ischemia, infarction, perforation)
  • Myocardial ischemia and heart failure
  • Myalgia (elevated CK)

Differential Diagnosis

Evaluation

Workup

Diagnosis

American College of Rheumatology Criteria

Need at least 3/10 (82% sensitivity and 87% specificity)

  • Unexplained weight loss greater than 4kg
  • Livedo reticularis
  • Testicular Pain or tenderness
  • Myalgia (excluding shoulder and hip girdle), weakness of muscles, tenderness of leg muscles, or polyneuropathy
  • Mononeuropathy or polyneuropathy
  • New-onset diastolic blood pressure > 90mmHg
  • Elevated serum BUN (>40mg/dL or 14.3mmol/L) or creatinine (>1.5mg/dL or 132 mmol/L)
  • Evidence of HBV infection (serology)
  • Characteristic arteriographic abnormalities not resulting fro noninflammatory disease processes
  • Biopsy of small- or medium-sized artery containing polymorphonuclear cells

Management

References

  • Reference: Rosen's Emergency Medicine 8th edition. 2013. Chapter: Erythematosus and the Vasculitides. p1539-1540.
  • Merkel PA, et al. Clinical manifestations and diagnosis of polyarteritis nodosa in adults. In: Post T, ed. UpToDate. Waltham, Mass.: UpToDate; 2014. www.uptodate.com. Accessed December 22, 2014.
  • Merkel PA, et al. Treatment and prognosis of polyarteritis nodosa. In: Post T, ed. UpToDate. Waltham, Mass.: UpToDate; 2014. www.uptodate.com. Accessed December 22, 2014.
  • Jacobs-Kosmin, D. (2014, Dec 12). Polyarteritis Nodosa. eMedicine. Retrieved 12/22/2014 from http://emedicine.medscape.com/article/330717-overview.